|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
|
|
|
|||||||||||||||||||||||||
| Test | 09 May 2025 | Reference Range | Unit |
|---|---|---|---|
| Leukocytes [#/volume] in Blood by Automated count | 9.7 | 4 - 11 | 10*3/uL |
| Erythrocytes [#/volume] in Blood by Automated count | 4.9 | 4.3 - 6.2 | 10*6/uL |
| Hemoglobin [Mass/volume] in Blood | 13.1 L | 13.5 - 17.5 | g/dL |
| Hematocrit [Volume Fraction] of Blood by Automated count | 47.4 | 37 - 52 | % |
| MCV [Entitic volume] by Automated count | 83.3 | 76 - 98 | fL |
| MCH [Entitic mass] by Automated count | 29.6 | 27 - 34 | pg |
| MCHC [Mass/volume] by Automated count | 35.3 | 31 - 37 | g/dL |
| Erythrocyte distribution width [Entitic volume] by Automated count | 45.3 | 36 - 55 | fL |
| Platelets [#/volume] in Blood by Automated count | 169.2 | 140 - 363 | 10*3/uL |
| Platelet distribution width [Entitic volume] in Blood by Automated count | 262.6 H | 13.5 - 17.4 | fL |
| Platelet mean volume [Entitic volume] in Blood by Automated count | 10.9 | 7.2 - 13.8 | fL |
| Test | 09 May 2025 | Reference Range | Unit |
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 6.1 | 4.5 - 6.4 | % |
| Glucose [Mass/volume] in Blood | 86.7 | 70 - 140 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 15.4 | 7 - 50 | mg/dL |
| Creatinine [Mass/volume] in Blood | 0.7 L | 0.8 - 1.3 | mg/dL |
| Calcium [Mass/volume] in Blood | 10.1 | 8.5 - 10.5 | mg/dL |
| Sodium [Moles/volume] in Blood | 137.8 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 4.8 | 3.5 - 5.3 | mmol/L |
| Chloride [Moles/volume] in Blood | 102.4 | 98 - 107 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 23.6 | 22 - 29 | mmol/L |
| Conclusion and Recommendations based on this report and previous findings known to us |
|---|
| The patient shows stable glucose control (HbA1c 6.1%) and normal renal function, though creatinine is slightly below reference, likely not clinically significant in this context. Mild anemia is present (Hb 13.1 g/dL), and lipid profile (2024) indicates elevated LDL, total cholesterol, and low HDL, suggesting increased cardiovascular risk. Platelet distribution width is elevated, which may reflect platelet activation or variability but requires clinical correlation. No acute abnormalities detected; recommend continued monitoring of anemia and lipid management. |